Machine Learning-Based Prediction of Protein-Ligand Binding Affinity for Kinase Inhibitor Discovery

Authors

  • Gallo V Department of Bioinformatics, University of Turin, Turin, Italy Author
  • Liepa J Department of Computational Biology, Riga Stradins University, Riga, Latvia Author
  • Dimitrova V Department of Pharmaceutical Chemistry, Medical University of Plovdiv, Plovdiv, Bulgaria Author

DOI:

https://doi.org/10.5281/zenodo.22637990

Keywords:

protein-ligand binding affinity, kinase inhibitors, machine learning, deep learning, drug-target interaction prediction

Abstract

Background: Accurate prediction of protein-ligand binding affinity is central to structure-based drug design, and protein kinases
remain among the most heavily pursued drug target classes because of their roles in cancer and inflammatory disease. Objective:
This narrative review synthesises the published literature on machine learning (ML) and deep learning (DL) approaches to
binding affinity prediction, with emphasis on their application to kinase inhibitor discovery. Methods: Peer-reviewed and
preprint literature was identified through PubMed, Google Scholar, Crossref and bioRxiv searches covering feature
representations, model architectures, benchmark datasets and validation strategies for protein-ligand affinity prediction.
Findings: Structure-based three-dimensional convolutional and graph models such as KDEEP, Pafnucy, OnionNet and PIGNet
achieve Pearson correlations of roughly 0.7-0.8 against the CASF-2016 PDBbind core-set benchmark, while sequence-based deep
networks such as DeepDTA and GraphDTA report concordance indices near 0.88-0.89 on the kinase-centred Davis and KIBA
datasets. Progress is constrained by dataset size, structural redundancy and scaffold bias, motivating scaffold-split and temporal
validation schemes and physics-informed architectures that improve generalisation to novel chemotypes. Conclusions: ML/DL
affinity predictors now approximate or complement classical scoring functions and free-energy methods for kinase inhibitor
triage, but rigorous, leakage-free benchmarking and integration with structural biology resources such as AlphaFold remain
priorities for translating these models into prospective drug discovery pipelines.

References

Jiménez J, Škalič M, Martínez-Rosell G, De Fabritiis G. KDEEP: protein-ligand absolute binding affinity prediction via 3D-convolutional neural networks. J Chem Inf Model. 2018;58(2):287-296. doi:10.1021/acs.jcim.7b00650. PMID:29309725.

Stepniewska-Dziubinska MM, Zielenkiewicz P, Siedlecki P. Development and evaluation of a deep learning model for protein-ligand binding affinity prediction. Bioinformatics. 2018;34(21):3666-3674. doi:10.1093/bioinformatics/bty374. PMID:29757353.

Zheng L, Fan J, Mu Y. OnionNet: a multiple-layer intermolecular-contact-based convolutional neural network for protein-ligand binding affinity prediction. ACS Omega. 2019;4(14):15956-15965. doi:10.1021/acsomega.9b01997. PMID:31592466.

Moon S, Zhung W, Yang S, Lim J, Kim WY. PIGNet: a physics-informed deep learning model toward generalized drug-target interaction predictions. Chem Sci. 2022;13(13):3661-3673. doi:10.1039/D1SC06946B.

Su M, Yang Q, Du Y, Feng G, Liu Z, Li Y, Wang R. Comparative assessment of scoring functions: the CASF-2016 update. J Chem Inf Model. 2019;59(2):895-913. doi:10.1021/acs.jcim.8b00545. PMID:30481020.

Öztürk H, Özgür A, Ozkirimli E. DeepDTA: deep drug-target binding affinity prediction. Bioinformatics. 2018;34(17):i821-i829. doi:10.1093/bioinformatics/bty593. PMID:30423097.

Nguyen T, Le H, Quinn TP, Nguyen T, Le TD, Venkatesh S. GraphDTA: predicting drug-target binding affinity with graph neural networks. Bioinformatics. 2021;37(8):1140-1147. doi:10.1093/bioinformatics/btaa921. PMID:33119053.

Davis MI, Hunt JP, Herrgard S, Ciceri P, Wodicka LM, Pallares G, Hocker M, Treiber DK, Zarrinkar PP. Comprehensive analysis of kinase inhibitor selectivity. Nat Biotechnol. 2011;29(11):1046-1051. doi:10.1038/nbt.1990. PMID:22037378.

Tang J, Szwajda A, Shakyawar S, Xu T, Hintsanen P, Wennerberg K, Aittokallio T. Making sense of large-scale kinase inhibitor bioactivity data sets: a comparative and integrative analysis. J Chem Inf Model. 2014;54(3):735-743. doi:10.1021/ci400709d. PMID:24521231.

Ain QU, Aleksandrova A, Roessler FD, Ballester PJ. Machine-learning scoring functions to improve structure-based binding affinity prediction and virtual screening. WIREs Comput Mol Sci. 2015;5(6):405-424. doi:10.1002/wcms.1225. PMID:27110292.

Cohen P, Cross D, Jänne PA. Kinase drug discovery 20 years after imatinib: progress and future directions. Nat Rev Drug Discov. 2021;20(7):551-569. doi:10.1038/s41573-021-00195-4. PMID:34002056.

Trott O, Olson AJ. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem. 2010;31(2):455-461. doi:10.1002/jcc.21334. PMID:19499576.

Ballester PJ, Mitchell JBO. A machine learning approach to predicting protein-ligand binding affinity with applications to molecular docking. Bioinformatics. 2010;26(9):1169-1175. doi:10.1093/bioinformatics/btq112. PMID:20236947.

Wang R, Fang X, Lu Y, Wang S. The PDBbind database: collection of binding affinities for protein-ligand complexes with known three-dimensional structures. J Med Chem. 2004;47(12):2977-2980. doi:10.1021/jm030580l.

Liu Z, Li Y, Han L, Li J, Liu J, Zhao Z, Nie W, Liu Y, Wang R. PDB-wide collection of binding data: current status of the PDBbind database. Bioinformatics. 2015;31(3):405-412. doi:10.1093/bioinformatics/btu626. PMID:25301850.

Gilson MK, Liu T, Baitaluk M, Nicola G, Hwang L, Chong J. BindingDB in 2015: a public database for medicinal chemistry, computational chemistry and systems pharmacology. Nucleic Acids Res. 2016;44(D1):D1045-D1053. doi:10.1093/nar/gkv1072. PMID:26481362.

Gaulton A, Hersey A, Nowotka M, Bento AP, Chambers J, Mendez D, Mutowo P, Atkinson F, Bellis LJ, Cibrián-Uhalte E, et al. The ChEMBL database in 2017. Nucleic Acids Res. 2017;45(D1):D945-D954. doi:10.1093/nar/gkw1074. PMID:27899562.

Mysinger MM, Carchia M, Irwin JJ, Shoichet BK. Directory of useful decoys, enhanced (DUD-E): better ligands and decoys for better benchmarking. J Med Chem. 2012;55(14):6582-6594. doi:10.1021/jm300687e. PMID:22716043.

Wallach I, Dzamba M, Heifets A. AtomNet: a deep convolutional neural network for bioactivity prediction in structure-based drug discovery. arXiv:1510.02855. 2015.

Karimi M, Wu D, Wang Z, Shen Y. DeepAffinity: interpretable deep learning of compound-protein affinity through unified recurrent and convolutional neural networks. Bioinformatics. 2019;35(18):3329-3338. doi:10.1093/bioinformatics/btz111. PMID:30768156.

Gilmer J, Schoenholz SS, Riley PF, Vinyals O, Dahl GE. Neural message passing for quantum chemistry. Proc Mach Learn Res. 2017;70:1263-1272.

Wu Z, Ramsundar B, Feinberg EN, Gomes J, Geniesse C, Pappu AS, Leswing K, Pande V. MoleculeNet: a benchmark for molecular machine learning. Chem Sci. 2018;9(2):513-530. doi:10.1039/C7SC02664A. PMID:29629118.

Chen L, Tan X, Wang D, Zhong F, Liu X, Yang T, Luo X, Chen K, Jiang H, Zheng M. TransformerCPI: improving compound-protein interaction prediction by sequence-based deep learning with self-attention mechanism and label reversal experiments. Bioinformatics. 2020;36(16):4406-4414. doi:10.1093/bioinformatics/btaa524. PMID:32428219.

Huang K, Xiao C, Glass LM, Sun J. MolTrans: molecular interaction transformer for drug-target interaction prediction. Bioinformatics. 2021;37(6):830-836. doi:10.1093/bioinformatics/btaa880. PMID:33070179.

Li S, Wan F, Shu H, Jiang T, Zhao D, Zeng J. MONN: a multi-objective neural network for predicting compound-protein interactions and affinities. Cell Syst. 2020;10(4):308-322.e11. doi:10.1016/j.cels.2020.03.002.

Stärk H, Ganea OE, Pattanaik L, Barzilay R, Jaakkola T. EquiBind: geometric deep learning for drug binding structure prediction. Proc Mach Learn Res. 2022;162:20503-20521.

Wang L, Wu Y, Deng Y, Kim B, Pierce L, Krilov G, Lupyan D, Robinson S, Dahlgren MK, Greenwood J, et al. Accurate and reliable prediction of relative ligand binding potency in prospective drug discovery by way of a modern free-energy calculation protocol and force field. J Am Chem Soc. 2015;137(7):2695-2703. doi:10.1021/ja512751q. PMID:25625324.

Jumper J, Evans R, Pritzel A, Green T, Figurnov M, Ronneberger O, Tunyasuvunakool K, Bates R, Žídek A, Potapenko A, et al. Highly accurate protein structure prediction with AlphaFold. Nature. 2021;596(7873):583-589. doi:10.1038/s41586-021-03819-2. PMID:34265844.

Downloads

Published

2024-07-19